Abstract
Urinary tract stones were known in prehistoric times. The oldest stone was unearthed in upper Egypt, dated approximately 4800 B.C. (Shattock, 1905). Stones have been discovered from Egyptian mummies of different dynasties (Miller, 1929; Wesson, 1935; Guthrie, 1946; Sigerist, 1951; Butt, 1956). Williams recorded one from North Arizona, estimated to be 3000 years old (Williams, 1926). Stone disease has been described from China and India (Thomson, 1921; McCarrison, 1931). Lithotomy was mentioned in ancient India in the first century B.C. (Guthrie, 1946). Stones were then almost exclusively found in the bladder, kidney stones being rare. For some unknown reason, the prevalence of bladder stones has decreased steadily from western countries since the turn of the century (Sallinen, 1959).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ablin, A., Stephens, B.G., Hirata, T., Wilson, H.K., Williams, H. E.: Nephropathy, xanthinuria and orotic aciduria, complicating Burkitt’s lymphoma treated with chemotherapy and allopurinol. Metabolism 21, 771–778 (1972)
Atsmon, A., Vries, A. de, Frank, M.: Uric Acid Lithiasis. Amsterdam: Elsevier 1963
Ball, G.V., Sorensen, L.B.: Pathogenesis of hyperuricemia in saturnine gout. New Engl. J. Med. 280, 1199–1202(1969)
Band, P.R., Silverberg, D.S., Henderson, J.F., Ulan, A.A., Wensel, R.H., Banerjee, T.K., Little, A.S.: Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. New Engl. J. Med. 283, 354–357 (1970)
Barzel, U.S., Sperling, O., Frank, M., Vries, A. de: Renal ammonium excretion and urinary pH in idiopathic uric acid lithiasis. J. Urol. 92, 1–5 (1964)
Becker, M.A., Meyer, L. J., Wood, A. W., Seegmiller, J.E.: Gout associated with increased PRPP synthetase activity. Arthr. and Rheum. 15, 430 (1972)
Benedict, J.D., Roche, M., Yü, T.F., Bien, E. J., Gutman, A.B., Stetten, W. de: The incorporation of glycine nitrogen in uric acid in normal and gouty man. Metabolism 1, 3–12 (1952 a)
Benedict, J.D., Yü, T.F., Bien, E. J., Gutman, A.B., Stetten, W de: A further study of the utilization of dietary glycine nitrogen for uric acid synthesis in gout. J. Clin. Invest. 32, 775–777 (1953 b)
Bennett, R.C., Jepson, R.P.: Uric acid stone formation following ileostomy. Aust. N. Z. J. Surg. 36, 153–158(1966)
Bergmann, F., Dikstein, S.: Relationship between spectral shifts and structural changes in uric acids and related compounds. J. Amer. Chem. Soc. 77, 691–696 (1955)
Bien, E. J., Yü, T.F., Benedict, J.D., Gutman, A.B., Stetten, W. de: The relation of dietary nitrogen consumption to the rate of uric acid synthesis in normal and gouty man. J. Clin. Invest. 32, 778–780 (1953)
Bodansky, M.: Introduction to Physiological Chemistry, 4th Ed. New York: John Wiley and Sons 1938
Bogash, M., Dowben, R.M.: Low protein diet in the management of uric acid stones. J. Urol. 72, 1057–1060 (1954)
Bollinger, A., Gross, R.: Ammonia, urea and uric acid content of toe nails in renal insufficiency and gout. Aust. exp. Biol. med. Sci. 31, 385–390 (1953)
Boston Collaborative Drug Surveillance Program: Allopurinol and cytotoxic drugs interaction in relation to bone marrow depression. J. Amer. med. Ass. 227, 1036–1040 (1974)
Bowering, J., Calloway, D.H., Margen, S., Kaufman, N.A.: Dietary protein level and uric acid metabolism in normal man. J. nutr. 100, 249–261 (1970)
Boyce, W.H., Garvey, F.K., Strawcutter, H.E.: Incidence of urinary calculi among patients in general hospitals, 1948–1952. J. Amer. med. Ass. 161, 1437–1442(1956)
Boyce, W.H., Garvey, F.K., Norfleet Jr., C.M.: The metal chelate compounds of urine. Their relation to the initiation and growth of calculi. Amer. J. Med. 19, 87–95 (1955)
Buchanan, J.M.: The enzymatic synthesis of the purine nucleotides. Harvey Lect. 54, 104–130 (1958/1959)
Butt, A.J. (Ed.): Etiological Factors in Renal Lithiasis. Springfield (Ill.): Ch. C. Thomas 1956
Campbell, J.W.: Nitrogen excretion Ch 7. In: Prosser, C.L. (Ed.): Comparative Animal Physiology, pp. 279–316. Philadelphia: W. B. Saunders 1973
Cifuentes, Delatte, L., Rapado, A., Abehsera, A., Traba, M.L., Cortes, M.: Uric acid lithiasis and gout in urinary calculi. Int. Symp. Renal Stones Res., Madrid, 1972, pp. 115–118
Clarke, A. M., McKenzie, R. G.: Ileostomy and the risk of urinary uric stones. Lancet II, 395–397 (1969)
Coe, F.L., Kavalach, A.G.: Hypercalciuria and hyperuricosuria in patients with nephrolithiasis. New Engl. J. Med. 291, 1344–1350 (1974)
Cottet, J., Weber, A.: Inter pratique de l’analyse clinique des calculs urinaire. Pathol. Biol. Sem. Hòp. 7, 1975–1978 (1959)
Davis, D.W.: Acetazolamide therapy with renal complication. Brit. med. J. I, 214–215 (1959)
Delbarre, F., Auscher, C., Lac, Y du: Documents pour l’étude du rein goutteux IV. Documents sur le pH-urinaire et ses variations. Rein Foie 6, 53–62 (1964)
Dent, C.E., Sutor, D.J.: Presence or absence of inhibitor of calcium oxalate crystal growth in urine of normal and of stone formers. Lancet 1971 II, 775–778 (1971)
Deren, J. J., Porush, J.G., Levitt, M.F., Khilnani, M.T.: Nephrolithiasis as a complication of ulcerative colitis and regional ileitis. Ann. Intern. Med. 56, 843–853 (1962)
Ebbinghaus, K.D., Prieber, S.: Die Behandlung hoher Harnleiterstein. Dtsch. med. Wschr. 85, 1045–1048 (1960)
Elion, G.B., Kovensky, A., Hitchings, G.H., Metz, E., Rundles, R.W.: Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem. Pharmacol. 15, 863–880 (1966 a)
Elion, G.B., Yü, T.F., Gutman, A.B., Hitchings, G. H.: Renal clearance of oxipurinol, the chief metabolite of allopurinol. Amer. J. Med. 45, 69–77 (1968)
Elliot, J.S, Sharp, R.F., Lewis, L.: Urinary pH. J. Urol. 81, 339–343 (1959)
Emmerson, B.T.: The clinical differentiation of lead gout from primary gout. Arthr. and Rheum. 11, 623–634(1968)
Falls W.F., Jr.: Comparison of urinary acidification and ammonium excretion in normal and gouty subjects. Metabolism 21, 433–445 (1972)
Feigelson, P., Davidson, J.D., Robins, R.K.: Pyrozolopyrimidines as inhibitors and substrates of xanthine oxidase. J. Biol. Chem. 226, 993–1000 (1957)
Finlayson, B., Meyers, A.S.: In: Finlayson, B., Hench, L.L., Smith, L.H. (Eds.): Stone Ultrastructure in Urolithiasis Physical Aspects, pp. 115–128. Washington, D.C.: National Academy of Sciences 1972
Frank, M., Vries, A. de, Atsmon, A., Kochwa, S.: Urinary pH, ammonia and calcium excretion in renal uric acid stone patients. Israel Med. J. 19, 299–301 (1960)
Gallagher, N.D., Harrison, D.D., Skyring, A.P.: Fluid and electrolyte disturbances in patients with long-established ileostomies. Gut 3, 219–223 (1962)
Gigax, J.H., Leach, J.R.: Uric acid calculi associated with ileostomy for ulcerative colitis. J. Urol. 105, 797–799 (1971)
Gill, W.B., Roma, M.J.: Determinants of supersaturation levels and crystallization rates of calcium oxalate from urine of normal humans and stone formers: Effects of nondialyzable materials. J. Surg. Res. 21, 45–49 (1976)
Goldfinger, S., Klinenberg, J.R., Seegmiller, J. E.: The renal excretion of oxypurines. J. Clin. Invest. 44, 623–628 (1965)
Grahame, R., Scott, J.T.: Clinical survey of 354 patients with gout. Ann. Rheum. Dis. 29, 461–468 (1970)
Greenberg, M.S., Zambrano, S. S.: Aplastic agranulocytosis after allopurinol therapy. Arthr. And Rheum. 15, 413–416 (1972)
Greene, M.L., Fujimoto, W.Y., Seegmiller, J.E.: Urinary xanthine stones: a rare complication of allopurinol therapy. New Engl. J. Med. 280, 426–427 (1969)
Grossman, M.S., Nugent, F.W.: Urolithiasis as a complication of chronic diarrheal disease. Amer. J. Dig. Dis. 12, 491–497 (1967)
Guthrie, D.: History of Medicine. Philadelphia: J. B. Lippincott 1946
Gutman, A.B., Yü, T.F.: Gout, a derangement of purine metabolism. Advanc. Intern. Med. 5, 227–302 (1952 a)
Gutman, A.B., Yü, T.F.: A three-component system for regulation of renal excretion of uric acid in man. Trans. Ass. Amer. Physcns 74, 353–365 (1961 b)
Gutman, A. B., Yü, T. F.: Urinary ammonium excretion in primary gout. J. Clin. Invest. 44, 1474–1481 (1965c)
Gutman, A.B., Yü, T.F.: Uric acid nephrolithiasis. Amer. J. Med. 45, 756–779 (1968d)
Hellstrom, J.: The significance of staphylococci in the development and treatment of renal and ureteral stones. Brit. J. Urol. 10, 348–372 (1938)
Henneman, P. A., Wallach, S., Dempsey, E.F.: The metabolic defect responsible for uric acid stone formation. J. Clin. Invest. 41, 537–542 (1962)
Herring, L. C.: Observations on the analysis of 10000 urinary calculi. J. Urol. 88, 545–562 (1962)
Hodgkinson, A.: Uric acid disorders in patients with calcium stones. Brit. J. Urol. 48, 1–5 (1976)
Holling, H.E.: Gout and glycogen storage disease. Ann. Intern. Med. 58, 654–663 (1963)
Hughes, J., Coppridge, W.M., Roberts, L.C., Mann, V.I.: Oxalate urinary tract stones. J. Amer. med. Ass. 172, 774–776 (1960)
Jarzobski, J., Ferrey, J., Wombolt, D., Fitch, D.M., Egan J. D.: Vascultis with allopurinol therapy. Amer. Heart J. 79, 116–121 (1970)
Jensen, A.T.: On concrements from the urinary tract. III. Acta Chir. Scand. 85, 473–500 (1941)
Kaufman, J.M., Greene, M.L., Seegmiller, J.E.: Urinary uric acid/creatinine ratio—a screening test for inherited disorders of purine metabolism. J. Pediat. 73, 583–592 (1968)
Kelley, W.M., Greene, M.L., Rosenbloom, F.M., Henderson, J.F., Seegmiller, J.E.: Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Ann. Intern. Med. 70, 155–206 (1969 c)
Kelley, W.M., Rosenbloom, F.M., Henderson, J.F., Seegmiller, J.E.: A specific enzyme defect in gout associated with overproduction of uric acid. Proc. Nat. Acad. Sci. (Wash.) 57, 1735–1739 (1967 a)
Kelley, W.M., Rosenbloom, F.M., Seegmiller, J.E., Howell, R.D.: Excessive production of uric acid in type I glycogen storage disease. J. Pediat. 72, 488–496 (1968 b)
King, J.S., Wainer, A.: Cystinuria with hyperuricemia and methioninuria. Amer. J. Med. 43, 125–130 (1967)
Klinenberg, J.R., Goldfinger, S.F., Seegmiller J.E.: The effectiveness of xanthine oxiase inhibitor allopurinol in the treatment of gout. Ann. Intern. Med. 62, 639–647 (1965)
Krakoff, I.H.: Studies of uric acid biosynthesis in the chronic leukemia. Arthr. and Rheum. 8, 772–779 (1965)
Krizek, V.: Anthropologische Merkmale und Nierensteinkrankheit. Dtsch. Z. Verdau.-Stoffwechselkr. 17, 133–139 (1957)
Krizek, V.: Uricemia in cystinuria. Horm. Metab. Res. 4, 51–53 (1972)
Kuzell, W.B., Seebach, L.M., Glover, R.P., Jackman, A.E.: Treatment of gout with allopurinol and sulfinpyrazone in combination and with allopurinol alone. Ann. Rheum. Dis. 25, 634–642 (1966)
Lagergren, C.: Biophysical investigation of urinary calculi. An X-ray crystallographic and microradiographic study. Acta Radiol. [Suppl.] 133, 1–71 (1956)
Landgrebe, A.R., Nyhan, W.L., Coleman, M.: Urinary tract stones resulting from the excretion of oxypurinol. New Engl. J. Med. 292, 626–627 (1975)
Laster, L., Muller, A.F.: Uric acid production in a case of myeloid metaplasia associated with gouty arthritis, studied with 15N-labeled glycine. Amer. J. Med. 15, 857–861 (1953)
Leonard, R.H.: Quantitative composition of kidney stones. Clin. Chem. 7, 546–551 (1961)
Lesch, M., Nyhan, W.L.: A familiar disorder of uric acid metabolism and central nervous system function. Amer. J. Med. 36, 561–570 (1964)
Lidsky, M.D., Sharp J. P.: Jaundice with the use of 4-hydroxypyrazolo (3, 4-d)-pyrimidine (4-HPP). Arthr. and Rheum. 10, 294 (1967)
Lonsdale, K.: Epitaxy as a growth factor in urinary calculi and gall stones. Nature (Lond.) 217, 56–58 (1968)
Lonsdale, K., Mason, P.: Uric acid, uric acid dihydrate and urates in urinary calculi, ancient, and modern. Science 152, 1511–1512 (1966)
Lynch, E. C.: Uric acid metabolism in proliferative diseases of the marrow. Arch. Intern. Med. 109, 639–653 (1962)
McCarrison, R.: A lecture on the causation of stone in India. Brit. Med. J. I, 1009–1015 (1931)
Maratka, Z., Nedbal, J.: Urolithiasis as a complication of the surgical treatment of ulcerative colitis. Gut 5, 214–217(1964)
May, P., Schindler, E.: Methods and results of conservative treatment of uric acid stones. In: Urinary Calculi. Int. Symp. Renal Stone Res., Madrid, 1972, pp. 111–114
Melick, R.A., Henneman, P. H.: Clinical and laboratory studies of 207 consecutive patients in a kidney stone clinic. New Engl. J. Med. 259, 307–314 (1958)
Meloni, C.R., Canary, J.J.: Cystinuria with hyperuricemia. J. Amer. med. Ass. 200, 169–171 (1967)
Metcalfe-Gibson, A., McCallum, F.M., Morrison, R.B.L, Wrong, O.: Urinary excretion of hydrogen ion in patients with uric acid calculi. Clin. Sci. 28, 325–342 (1965)
Meyer, A. S., Finlayson, B., Dubois, L.: Direct observation of urinary stone ultrastructure. Brit. J. Urol. 43, 154–163 (1971)
Meyer, J.: Über die Ausfallung von Sedimenten und die Bildung von Konkrementen in den Harnwegen. Z. klin. Med. 111, 613–687 (1929)
Miller, J.L.: Some diseases of ancient man. Ann. med. Hist. 1, 394–402 (1929)
Mills, Jr., R.M.: Severe hypersensitivity reactions associated with allopurinol. J. Amer. med. Ass. 216, 799–802(1971)
Nicholas, H.O.: Urinary calculi. III. Further observations on calculi from patients in the southeast Texas area. Clin. Chem. 7, 175–177 (1961)
Nugent, C.A., MacDiarmid, W.D., Tyler, F.H.: Renal excretion of uric acid in leukemia and gout. Arch, intern. Med. 109, 540–544 (1962)
Nyhan, W.L., Oliver, W.J., Lesch, M.: A familiar disorder of uric acid metabolism and central nervous system function. II. J. Pediat. 67, 257–263 (1965)
Pak, C.Y.C., Arnold, L.H.: Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc. Soc. Exp. Biol. Med. (N.Y.) 149, 930–932 (1975)
Peters, J.P., Van Slyke, D.D.: Quantitative clinical chemistry, 2nd Ed., Vol. I. Baltimore: Williams and Wilkins 1946
Pinto, B., Rocha, E., Ruiz-Marcellán, F. J.: Isolation and characterization of uricine from uric acid stones. Kidney Int. 10, 437–443 (1976)
Plante, G.E., Durivage, J., Lemieux, G.: Renal excretion of hydrogen in primary gout. Metabolism 17, 377–385 (1968)
Prien, E. L.: Crystallographic analysis of urinary calculi; a 25 year survey study. J. Urol. 89, 917–924 (1963)
Prien, E.L., Prien Jr., E.L.: Composition and structure of urinary stone. Amer. J. Med. 45, 654–672 (1968)
Rapoport, A., Crassweller, P. O., Husdan, H., From, G.L.A., Zweig, M., Johnson, M.D.: The renal excretion of hydrogen ion in uric acid stone formers. Metabolism 16, 176–188 (1967)
Reisner, G.S., Wilansky, D.L., Schneiderman, S.: Uric acid lithiasis in the ileostomy patient. Brit. J. Urol. 45, 340–343 (1973)
Richet, G., Mignon, F., Ardaillou, R.: Goutte secondaire de nephropathies chroniques, Presse Méd. 73, 633–638 (1965)
Rieselbach, R.E., Bentzel, C.J., Cotlove, E., Erei, E. III., Freireich, E.J.: Uric acid excretion and renal function in the acute hyperuricemia of leukemia Pathogenesis and therapy of uric acid nephropathy. Amer. J. Med. 37, 872–884 (1964)
Rundles, R. W., Wyngaarden J.B., Hitchings, G., Elion, G.B., Silberman, H.R.: Effects of xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout. Trans. Ass. Amer. Physcns 76, 126–140 (1963)
Sallinen, H.: Some aspects of urolithiasis in Finland. Acta Chir. Scand. 118, 479–487 (1959)
Sandberg, A.A., Cartwright, G.E., Wintrobe, M.M.: Studies of leukemia: I uric acid excretion. Blood 11, 154–166 (1956)
Sarre, H., Mertz, D.P.: Sekundäre Gicht bei Niereninsuffizienz. Klin. Wschr. 43, 1134–1140 (1965)]
Seze, S. de, Ryckewaert, A.: La Goutte. Paris: Expansion Scientifique Francaise 1960
Shattock, S. G.: A prehistoric or predynastic Egyptian calculus. Trans. Path. Soc. (Lond.) 56, 275–291 (1905)
Sigerist, H. E.: A History of Medicine. New York: Oxford Univ. Pr. 1951
Simons, F., Feldman, B., Gerety, D.: Granulomatous hepatitis in a patient receiving allopurinol. Gastroenterology 62, 101–104 (1972)
Smith, M.J., Hunt, L.D., King Jr., J.S., Boyce, W.H.: Uricemia and urolithiasis. J. Urol. 101, 637–642 (1969)
Sorensen, L.B.: Role of the intestinal tract in the elemination of uric acid. Arthr. and Rheum. 8, 694–706 (1965)
Sperling, O., Persky-Brosh, S., Boer, P., Vries, A. de: Uric acid lithiasis associated with excessive purine production due to mutant PRPP synthetase. In: Urinary Calculi. Int. Symp. Renal Stone Res., Madrid, 1972, pp. 96–104
Sperling, O., Vries, A. de, Kedem, O.: Studies on the etiology of uric acid lithiasis. IV. Urinary non-dialyzable substances in idiopathic uric acid lithiasis. J. Urol. 94, 286–292 (1965)
Stratigos, J.D., Bartsokas, S. K., Capetanakis, J.: Further experiences of toxic epidermal necrolysis incriminating allopurinol pyrazolone and derivatives. Brit. J. Derm. 86, 564–567 (1972)
Sutor, D. J.: Growth studies of calcium oxalate in presence of various ions and compounds. Brit. J. Urol. 41, 171–178 (1969)
Sutor, D.J.: In: Finlayson, B., Hench, L., Smith, L.H. (Eds.): The Nature of Urinary Stones in Urolithiasis; Physical Aspects, pp. 43–46. Washington, D.C.: Nat. Acad. Sci. 1972
Sutor, D.J., Wooley, S.E., Illingsworth, J.J.: Some aspects of the adult urinary stone problem in Great Britain and Northern Ireland. Br. J. Urol. 46, 275–288 (1974)
Talbott, J.H.: Gout and blood dyscrasias. Medicine 38, 173–205 (1959)
Talbott, J. H., Yü, T.F.: Gout and Uric Acid Metabolism. New York: Stratton Inter. med. Book Co. 1976
Thomson, J. O.: Urinary calculus at the Canton Hospital, Canton, China. Surg. Gynec. Obstet. 32, 44–55(1921)
Vergis, J.G., Walker, B.R.: Cystinuria, hyperuricemia and uric acid nephrolithiasis. Nephron 7, 577–579 (1970)
Vermeulen, C.W., Fried, F.A.: Observations on dissolution of uric acid calculi. J. Urol. 94, 293–296 (1965)
Vermeulen, C.W., Lyon, E.S.: Mechanisms of genesis and growth of calculi. Amer. J. Med. 45, 684–692 (1968)
Vesell, E.S., Passananti, G.T., Greene, F.E.: Impairment of drug metabolism in man by allopurinol and nortriptyline. New Engl. J. Med. 283, 1484–1488 (1970)
Vries, A. de, Frank, M., Atsrnon, A.: Inherited uric acid lithiasis. Amer. J. Med. 33, 880–892 (1962)
Wardlaw, H.S.H.: Observation on the incidence and composition of urinary calculi. Med. J. Aust. 1, 180–186 (1952)
Wasserman, L.R.: Polycythemia vera study group, sponsored by National Cancer Institute, USPHS. Personal communication, 1975
Weiss, T.E., Segaloff, A.: Gouty Arthritis and Gout. Springfield (Ill.): Charles C. Thomas 1959 Wesson, M. B.: Renal calculi; etiology and prophylaxis. J. Urol. 34, 289–295 (1935)
Williams, G.D.: An ancient bladder stone. J. Amer. med. Ass. 87, 941 (1926)
Wilmore, D.W., Gots, R.E.: The etiology of uric acid urolithiasis following ileostomy. Arch. Surg. 99, 421–423 (1969)
Woeber, K. A., Ricca, L., Hills, A.G.: Pathogenesis of uric acid urolithiasis. Clin. Res. 10, 45 (1962)
Yendt, E.R.: Renal calculi. Canad. MA J. 102, 479–489 (1970)
Yü, T.F.: Secondary gout associated with myeloproliferative diseases. Arthr. and Rheum. 8, 765–771 (1965)
Yü, T.F.: Milestones in the treatment of gout. Am. J. Med. 56, 676–685 (1974)
Yü, T.F.: Some unusual features of gout in females. Semin. Arthritis Rheum. 6, 247–255 (1977)
Yü, T.F., Balis, M.E., Krenitsky, T.A., Dancis, J., Silvers, D.N., Elion, G.B., Gutman, A.B.: Rarity of X-linked partial hypoxanthine guanine phosphoribosyltransferase deficiency in a large gouty population. Ann. Intern. Med. 76, 255–264 (1972)
Yü, T.F., Balis, M.E., Yip, L.: Overproduction of uric acid in primary gout. Arthr. and Rheum. [Suppl.] 18, 695–698(1975)
Yü, T.F, Berger, L.: Renal disease in primary gout; a study of 253 gouty patients with proteinuria. Semin. Arthritis Rheum. 4, 293–305 (1975)
Yü, T.F., Gutman, A.B.: Effect of allopurinol (4-hydroxypyrazolo(3, 4-d)-pyrimidine) on serum and urinary uric acid in primary and secondary gout. Amer. J. Med. 37, 885–898 (1964)
Yü, T.F., Gutman, A.B.: Uric acid nephrolithiasis in gout predisposing factors. Ann. intern. Med. 67, 1133–1148(1967)
Yü, T.F., Wasserman, L.R., Benedict, J.D., Bien, E.J., Gutman, A.B., Stetten, de W.,: A simultaneous study of glycine-15N incorporation into uric acid and heme and of 59Fe utilization, in a case of gout associated with polycythemia secondary to congenital heart disease. Amer. J. Med. 15, 845–856 (1953)
Yü, T.F., Weinreb, N., Wittman, R., Wasserman, L.R.: Secondary gout associated with chronic myeloproliferative disorders. Semin. Arthritis Rheum. 5, 247–256 (1976)
Yü, T.F., Weissmann, B., Sharney, L., Kupfer, S., Gutman, A.B.: On the biosynthesis of uric acid from glycine-15N in primary and secondary polycythemia. Amer. J. Med. 21, 901–917 (1956)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg Boston
About this chapter
Cite this chapter
Yü, TF. (1978). Uric Acid Nephrolithiasis. In: Kelley, W.N., Weiner, I.M. (eds) Uric Acid. Handbook of Experimental Pharmacology, vol 51. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66867-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-66867-8_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66869-2
Online ISBN: 978-3-642-66867-8
eBook Packages: Springer Book Archive